Altimmune, Inc.
ALT
$5.61
-$0.36-6.03%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.47% | 7.28% | -1.01% | 22.90% | -53.07% |
| Total Depreciation and Amortization | -10.81% | -39.34% | -42.99% | -6.14% | 120.65% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 15.86% | -37.04% | 23.93% | -81.13% | 423.38% |
| Change in Net Operating Assets | 138.52% | -302.69% | -39.94% | 540.07% | 141.63% |
| Cash from Operations | 32.65% | -49.76% | -10.70% | 1.06% | 19.30% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1,036.95% | 132.44% | 90.65% | -396.56% | -280.80% |
| Cash from Investing | 1,036.95% | 132.44% | 90.65% | -396.56% | -280.80% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3,635.93% | 36.36% | -41.59% | -99.53% | 12,237.46% |
| Repurchase of Common Stock | 50.00% | 98.36% | 59.33% | -1,521.62% | -1,750.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 3,691.35% | 678.26% | 82.38% | -100.36% | 12,273.13% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 121.25% | -17.41% | 61.08% | -216.32% | 411.43% |
